|
GATAD2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.98030000000094E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.279780E-02 |
| Normal-vs-Stage2 |
3.221400E-03 |
| Normal-vs-Stage3 |
2.55950000005445E-06 |
| Normal-vs-Stage4 |
3.54939999946957E-07 |
| Stage1-vs-Stage2 |
1.660760E-01 |
| Stage1-vs-Stage3 |
4.322700E-03 |
| Stage1-vs-Stage4 |
1.083230E-03 |
| Stage2-vs-Stage3 |
5.248200E-01 |
| Stage2-vs-Stage4 |
2.434600E-01 |
| Stage3-vs-Stage4 |
4.612600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.395440E-04 |
| Normal-vs-AfricanAmerican |
7.7057000000047E-05 |
| Normal-vs-Asian |
6.006600E-01 |
| Caucasian-vs-AfricanAmerican |
1.188250E-01 |
| Caucasian-vs-Asian |
6.694100E-02 |
| AfricanAmerican-vs-Asian |
3.465700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.8446999999997E-05 |
| Normal-vs-Female |
3.081000E-03 |
| Male-vs-Female |
6.527700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.178010E-02 |
| Normal-vs-Age(41-60Yrs) |
2.737900E-03 |
| Normal-vs-Age(61-80Yrs) |
2.21860000004792E-06 |
| Normal-vs-Age(81-100Yrs) |
9.237100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.502000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.408600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.789600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.438300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.048830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.510000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.686600E-01 |
| Normal-vs-Grade 2 |
1.772370E-02 |
| Normal-vs-Grade 3 |
4.43979999986688E-07 |
| Normal-vs-Grade 4 |
3.40710000212852E-08 |
| Grade 1-vs-Grade 2 |
4.679700E-02 |
| Grade 1-vs-Grade 3 |
4.043200E-04 |
| Grade 1-vs-Grade 4 |
4.44230000000712E-05 |
| Grade 2-vs-Grade 3 |
6.756100E-04 |
| Grade 2-vs-Grade 4 |
4.15180000000737E-05 |
| Grade 3-vs-Grade 4 |
1.242970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.040610E-01 |
| Normal-vs-ccB subtype |
2.3970999999956E-05 |
| ccA subtype-vs-ccB subtype |
1.585190E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.413500E-04 |
| Normal-vs-N1 |
8.939600E-03 |
| N0-vs-N1 |
4.891200E-01 |
|
|
